Disease X: CEPI partners with Pune-based Gennova Biopharmaceuticals to develop mRNA vaccine tech against deadly virus
Shortpedia
Content Team
Image Credit: verify this
The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced a new funding agreement with Pune-based Gennova Biopharmaceuticals to advance the development of their self-amplifying mRNA (saRNA) platform to develop vaccine candidates against unknown pathogenic threats, also referred to as 'Disease X'.
